The article provides an overview of female breast cancer statistics in the United States for 2011, including incidence, mortality, survival, and screening trends. Approximately 230,480 new cases and 39,520 deaths are expected among US women in 2011. Breast cancer incidence rates were stable from 2004 to 2008 across all racial/ethnic groups, while death rates have been declining since the early 1990s for all women except American Indians/Alaska Natives. Disparities in breast cancer death rates exist by state, socioeconomic status, and race/ethnicity. While significant declines in mortality rates were observed in 36 states and the District of Columbia over the past decade, rates in 14 states remained stable. County-level poverty rates showed that the decrease in mortality rates began later and was slower among women in poor areas. Screening rates are lower in poor women compared to non-poor women, despite progress in increasing mammography utilization. The article emphasizes the importance of annual mammography and clinical breast examinations for patients aged 40 and older, as well as identifying and offering appropriate screening and follow-up to high-risk patients. Continued efforts are needed to provide high-quality screening, diagnosis, and treatment to all segments of the population.The article provides an overview of female breast cancer statistics in the United States for 2011, including incidence, mortality, survival, and screening trends. Approximately 230,480 new cases and 39,520 deaths are expected among US women in 2011. Breast cancer incidence rates were stable from 2004 to 2008 across all racial/ethnic groups, while death rates have been declining since the early 1990s for all women except American Indians/Alaska Natives. Disparities in breast cancer death rates exist by state, socioeconomic status, and race/ethnicity. While significant declines in mortality rates were observed in 36 states and the District of Columbia over the past decade, rates in 14 states remained stable. County-level poverty rates showed that the decrease in mortality rates began later and was slower among women in poor areas. Screening rates are lower in poor women compared to non-poor women, despite progress in increasing mammography utilization. The article emphasizes the importance of annual mammography and clinical breast examinations for patients aged 40 and older, as well as identifying and offering appropriate screening and follow-up to high-risk patients. Continued efforts are needed to provide high-quality screening, diagnosis, and treatment to all segments of the population.